Fund Sets $2.4 Billion To Fight Against AIDS, Malaria, TB


Use Article Email Facebook Digg Twitter Buzz Up! Share
November 16, 2009 12:31 p.m. EST

Topics: Health, World
Windsor Genova - AHN News Writer

Addis Ababa, Ethiopia (AHN) - The Global Fund to Fight AIDS, Tuberculosis and Malaria has set a $2.4 billion grant to implement its program in the next two years.

"These grants enable countries around the world to address some of the main problems they are struggling with every day," said Dr. Tedros Adhanom Ghebreyesus, Ethiopian Health Minister and Chair of the Global Fund Board, in a press release. "These grants are based on the countries' own needs and priorities and they are therefore a particularly effective source of financing."

The Global Fund's board of directors will launch the grants in May next year.

Meanwhile, the Fund revealed that it approved a program to reduce prices for effective malaria medicines in nine African countries and Cambodia through a $216 million funding from UNITAID, the United Kingdom government and the Bill and Melinda Gates Foundation.

Formed in 2002, the Global Fund is the dominant financier of programs to fight AIDS, tuberculosis and malaria. It has $ 18.4 billion in grants for more than 600 programs in 144 countries saving 4.5 million lives through AIDS treatment for 2.3 million people, anti-tuberculosis treatment for 5.4 million people and the distribution of 88 million insecticide-treated bed nets for the prevention of malaria.


Copyright © 2003 - 2010 AHN - All rights reserved.
Redistribution, republication. syndication, rewriting or broadcast is prohibited without the prior written consent of AHN.
License real time content for your website, business, digital signage network or publication.

[ Close ]

When publishing articles from AHN we require that you follow several simple rules and that you abide by our Terms and Conditions.


You are free:

  • To use and display the provided article text on a website or blog.

Under the following conditions:

  • You must display and attribute the article in the manner specified by AHN (but not in any way that suggests that we endorse you or your use of the work).
  • You may not remove ads, logos or tracking information from the article.
  • You may display the article on a website, but you may not use the article for any other commercial purposes.
  • You may not alter, rewrite, transform, or build upon the article.
  • You may only use provided the javascript code to request the article from our systems.

Copy and paste the following into your blog entry or the HTML on your page.
It will automatically deliver the article as the page loads.

Need more news? visit FeedSyndicate for all of your content needs

This is a BETA service and subject to change or cancellation.